Sasha Jovanovic
5 min read
AI heavyweights are wrestling with questions about debt, demand and whether today’s big bets will pay off, while many smaller AI infrastructure players now face what some analysts call a potential tech death spiral. That kind of uncertainty can push investors to look for lower priced shares in financially solid smaller businesses. This article highlights three such under 5 stocks, each screened for stronger balance sheet health and cash discipline.
The three stocks highlighted here offer a compelling starting point if you want exposure to lower risk early-stage businesses with tighter financial discipline. However, if you want the strongest names, these 7 elite penny stocks are at the top of the list.
Nuvation Bio (NUVB)
Overview: Nuvation Bio is a clinical-stage oncology company developing and commercializing targeted cancer therapies, led by IBTROZI for ROS1+ lung cancer and safusidenib for IDH1-mutant brain tumors.
Operations: The business generates about US$170 million from oncology development activities, with roughly US$124 million from the United States and the remainder from China and Japan.
Market Cap: US$1.7b
Nuvation Bio fits the Financially Fit Penny Stocks theme because it couples late-stage oncology drugs with a balance sheet designed to shoulder that clinical workload, giving you exposure to real assets rather than just early lab concepts.
“IBTROZI is rapidly emerging as the preferred therapy in ROS1 positive non small cell lung cancer, with best in class durability, strong brain penetration and growing first line use.”
What happens to Nuvation Bio’s margin potential if one unresolved pressure on how those treatments are funded globally breaks in its favour?
If that funding pressure ever tilts Nuvation Bio’s way, the full narrative for Nuvation Bio shows how the story could accelerate beyond early oncology promise.
Grab Holdings (GRAB)
Overview: Grab Holdings runs a Southeast Asian superapp where ride-hailing and food delivery help feed a growing GrabFin and GrabPay financial-services ecosystem.
Operations: Grab generates about US$3.7b in annual revenue, with US$1.99b from Deliveries, US$1.31b from Mobility, and US$430 million from Financial Services, primarily across Malaysia, Singapore and Indonesia.
Market Cap: US$11.6b
Grab Holdings fits the Financially Fit Penny Stocks theme because its GrabFin and GrabPay services add a financial spine to the app, aiming to turn everyday rides and food orders into more predictable payments and lending income.
“Financial Services may eventually become Grab’s second economic engine. Revenue there increased 59%, while the segment’s adjusted EBITDA loss narrowed from $26 million to $15 million.”
